No phaseCompleted
This Study Evaluates the Impact of the Sodium Management Tool (SMT) on Hemodialysis Patient Outcomes Compared to Standard Care (SOMADIA)
Sodium Management Tool in Hemodialysis Patients
- Sponsor
- Luzerner Kantonsspital (Academic or other)
- Enrollment
- 36 enrolled
- Conditions
- Hemodialysis; Interdialytic Weight Gain; Intradialytic Hypotension
- Interventions
- dialysis assisted with the sodium management tool
- Ages
- adults, older adults
- Registry
- NCT06896786
Full record on ClinicalTrials.gov
From the registry
Title of the Study: Sodium Management Tool in Hemodialysis Patients Brief Summary: The goal of this clinical trial is to learn whether the Sodium Management Tool (SMT) can improve patients clnical outcomes. The main questions this study aims to answer are: Does the SMT help reduce weight gain between dialysis sessions? Does the SMT improve dialysis tolerance by reducing symptoms like low blood pressure and muscle cramps? Researchers will compare standard dialysis to dialysis using the SMT to see if clinical outcomes are better in dialysis that use the SMT. Participants will: Receive dialysis three times per week with either standard dialysis or SMT-activated dialysis Switch between standard dialysis and SMT-activated dialysis after 4 weeks Have their blood pressure, sodium levels, and symptoms monitored during treatment Report their symptoms and thirst levels in a questionnaire Some participants may continue for an additional 4 weeks with a personalized SMT setting based on their symptoms and weight changes. This study will help determine whether the SMT can improve sodium…
Primary outcomes
- mean relative interdialytic weight gain (rIDWG)
History
Last registry update
Primary completion
Started
Registered